| Ytd | -88.06% | |
| 1y | -92.00% |
| Open | 1.34 | Prev Close | 1.35 | Low | 1.15 | High | 1.34 | Mkt Cap | 22.03M |
| Vol | 379.82K | Avg Vol | 205.75K | EPS | 382.20 | P/E | 0.00 | Forward P/E | -2.14 |
| Beta | 1.60 | Short Ratio | 0.56 | Inst. Own | 18.81% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-30 | 50-d Avg | 4.44 | 200-d Avg | 11.60 | 1yr Est | 9.50 |
ENLV News
Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 50.7% to $3.27 during Thursday's after-market
Gainers Picard Medical (AMEX:PMI) stock rose 40.2% to $4.5 during Friday's after-market session
BioStem Technologies (OTCMKTS:BSEM - Get Free Report) and Enlivex Therapeutics (NASDAQ: ENLV - Get F
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Enlivex (NASDAQ:ENLV) with a Buy and
Enlivex Ltd. (NASDAQ:ENLV, "Enlivex" or the "Company")), a quality longevity company
As of July 29, 2026, trading volume on the Rain protocol reached $860MM1 622% month-over-month grow
Webinar to cover the rationale and value creation potential of the recently announced private placem
Gainers OPKO Health (NASDAQ:OPK) shares increased by 34.7% to $1.67 during Tuesday's regular se
US stocks trade higher, Dow up 1% on Tuesday. Boeing gains 5% after reporting Q2 results. Kiniksa Ph
Dow Jones up 350 points, NASDAQ down. Coca-Cola shares rise 6% after better-than-expected earnings.
Price of $5.00 per share for subscription amounts funded in U.S. dollars, USDT or USD Coin and $6.00
Nes-Ziona, Israel, July 28, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or “the C
Enlivex Therapeutics (NASDAQ: ENLV - Get Free Report) and Korro Bio (NASDAQ: KRRO - Get Free Report)
Nes-Ziona, Israel, July 20, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, "Enlivex" or the "C
Enlivex Ltd. (ENLV) might move higher on growing optimism about its earnings prospects, which is ref
The heavy selling pressure might have exhausted for Enlivex Ltd. (ENLV) as it is technically in over
Nes-Ziona, Israel, July 13, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) ("Enlivex" or the "
Nes-Ziona, Israel, July 07, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) ("Enlivex" or the "
Nes-Ziona, Israel, June 24, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “ Enlivex ” or the
Enlivex Ltd. (NASDAQ:ENLV, "Enlivex" or the "Company")), a quality longevity company
Nes-Ziona, Israel, June 22, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, "Enlivex" or the "C
The patent will provide Enlivex with added intellectual property protection in Australia through at
Nes-Ziona, Israel, June 15, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) ("Enlivex" or the "
As a Gold Sponsor of the Paris event, Enlivex will host a curated dinner today for leading instituti
The data were selected for an oral podium presentation at EULAR and will be presented by Prof. Phili
The data were selected for an oral podium presentation at EULAR and will be presented by Prof. Phili
As of May 27, 2026, Enlivex held 79,568,550,005 RAIN tokens with a total value of approximately $1.1
Rain, with an additional $100 Million Liquidity Commitment, Currently Anchors Top Three Positioning
The global, multicenter, randomized, double-blind, placebo-controlled Phase 2b clinical trial is des
Enrollment milestone follows FDA IND clearance received in March 2026 and Danish Medicines Agency (D
Nes-Ziona, Israel, May 15, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, "Enlivex" or the "Co
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Enlivex (NASDAQ:ENLV) with a Buy and
The U.S. Food and Drug Administration (FDA) has cleared Enlivex's Investigational New Drug (IND)
Enlivex's RAIN token begins trading on KuCoin as analysts raise price targets, citing growing pr
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Enlivex Therapeutics (NASDAQ:ENLV) w
– Enlivex has adopted the world's first RAIN prediction markets token digital asset treasury str
Enlivex raises $212 million at a premium to fund its RAIN prediction markets strategy and expand its
Enlivex Therapeutics Ltd. (NASDAQ:ENLV, the "Company"))), a clinical-stage macrophage reprog
D. Boral Capital analyst Jason Kolbert maintains Enlivex Therapeutics (NASDAQ:ENLV) with a Buy an
Enlivex Therapeutics Ltd. (NASDAQ:ENLV, the "Company"))), a clinical-stage macrophage reprog
D. Boral Capital analyst Jason Kolbert maintains Enlivex Therapeutics (NASDAQ: ENLV) with a Buy a
D. Boral Capital analyst Jason Kolbert maintains Enlivex Therapeutics (NASDAQ:ENLV) with a Buy an
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-th